B Cell Abnormalities in Systemic Lupus Erythematosus and Lupus Nephritis—Role in Pathogenesis and Effect of Immunosuppressive Treatments
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
B Cell Abnormalities in Systemic Lupus Erythematosus and Lupus Nephritis—Role in Pathogenesis and Effect of Immunosuppressive Treatments
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 24, Pages 6231
Publisher
MDPI AG
Online
2019-12-10
DOI
10.3390/ijms20246231
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sustained B cell depletion by CD19-targeted CAR T cells is a highly effective treatment for murine lupus
- (2019) Rita Kansal et al. Science Translational Medicine
- Lupus-associated atypical memory B cells are mTORC1-hyperactivated and functionally dysregulated
- (2019) Chunmei Wu et al. ANNALS OF THE RHEUMATIC DISEASES
- 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
- (2019) Antonis Fanouriakis et al. ANNALS OF THE RHEUMATIC DISEASES
- Abatacept modulates CD80 and CD86 expression and memory formation in human B-cells
- (2019) Raquel Lorenzetti et al. JOURNAL OF AUTOIMMUNITY
- TACI deletion protects against progressive murine lupus nephritis induced by BAFF overexpression
- (2018) Tanvi Arkatkar et al. KIDNEY INTERNATIONAL
- Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial
- (2018) Zhi-Wei Lai et al. LANCET
- Review: Abnormal B Cell Development in Systemic Lupus Erythematosus: What the Genetics Tell Us
- (2018) Sarah Karrar et al. Arthritis & Rheumatology
- The Calcineurin Inhibitor Tacrolimus Specifically Suppresses Human T Follicular Helper Cells
- (2018) Elizabeth F. Wallin et al. Frontiers in Immunology
- Plasma Cell Differentiation Pathways in Systemic Lupus Erythematosus
- (2018) Susan Malkiel et al. Frontiers in Immunology
- Phase III trial results with blisibimod, a selective inhibitor of B-cell activating factor, in subjects with systemic lupus erythematosus (SLE): results from a randomised, double-blind, placebo-controlled trial
- (2018) Joan T Merrill et al. ANNALS OF THE RHEUMATIC DISEASES
- Peripheral Blood B Cell Depletion after Rituximab and Complete Response in Lupus Nephritis
- (2018) Liliana Michelle Gomez Mendez et al. Clinical Journal of the American Society of Nephrology
- B-cell therapy in lupus nephritis: an overview
- (2018) Salem Almaani et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Longterm Data on Sirolimus Treatment in Patients with Lupus Nephritis
- (2018) Desmond Y.H. Yap et al. JOURNAL OF RHEUMATOLOGY
- A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis
- (2018) Brad H. Rovin et al. KIDNEY INTERNATIONAL
- B cell alterations during BAFF inhibition with belimumab in SLE
- (2018) Daniel Ramsköld et al. EBioMedicine
- Cytokines in systemic lupus erythematosus: far beyond Th1/Th2 dualism lupus: cytokine profiles
- (2017) Poliana Macedo Guimarães et al. IMMUNOLOGY AND CELL BIOLOGY
- B cell–derived IL-6 initiates spontaneous germinal center formation during systemic autoimmunity
- (2017) Tanvi Arkatkar et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Longterm Data on Disease Flares in Patients with Proliferative Lupus Nephritis in Recent Years
- (2017) Desmond Y.H. Yap et al. JOURNAL OF RHEUMATOLOGY
- The short-term efficacy of bortezomib combined with glucocorticoids for the treatment of refractory lupus nephritis
- (2017) H Zhang et al. LUPUS
- Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials
- (2017) Megan E. B. Clowse et al. Arthritis & Rheumatology
- Efficacy and safety of an interleukin 6 monoclonal antibody for the treatment of systemic lupus erythematosus: a phase II dose-ranging randomised controlled trial
- (2016) Daniel J Wallace et al. ANNALS OF THE RHEUMATIC DISEASES
- The impact of tabalumab on the kidney in systemic lupus erythematosus: results from two phase 3 randomized, clinical trials
- (2016) B H Rovin et al. LUPUS
- Multitarget Therapy for Induction Treatment of Lupus Nephritis
- (2015) Zhihong Liu et al. ANNALS OF INTERNAL MEDICINE
- The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus
- (2015) Tobias Alexander et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study
- (2015) J T Merrill et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of subcutaneous tabalumab in patients with systemic lupus erythematosus: results from ILLUMINATE-1, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study
- (2015) D A Isenberg et al. ANNALS OF THE RHEUMATIC DISEASES
- B cell autophagy mediates TLR7-dependent autoimmunity and inflammation
- (2015) Chi G Weindel et al. Autophagy
- Pathogenesis of Renal Disease in Systemic Lupus Erythematosus—The Role of Autoantibodies and Lymphocytes Subset Abnormalities
- (2015) Desmond Yap et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus
- (2015) D C Salazar-Camarena et al. LUPUS
- Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus
- (2015) Christopher M Tipton et al. NATURE IMMUNOLOGY
- RNA sensing by conventional dendritic cells is central to the development of lupus nephritis
- (2015) Teja Celhar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Differential effects of cyclophosphamide and mycophenolate mofetil on cellular and serological parameters in patients with systemic lupus erythematosus
- (2015) Till Fassbinder et al. ARTHRITIS RESEARCH & THERAPY
- Differential Effects of Tacrolimus versus Sirolimus on the Proliferation, Activation and Differentiation of Human B Cells
- (2015) Opas Traitanon et al. PLoS One
- Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up
- (2014) Chi Chiu Mok et al. ANNALS OF THE RHEUMATIC DISEASES
- T/B-cell interactions are more transient in response to weak stimuli in SLE-prone mice
- (2014) Parisa Sinai et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Opposing Impact of B Cell-Intrinsic TLR7 and TLR9 Signals on Autoantibody Repertoire and Systemic Inflammation
- (2014) S. W. Jackson et al. JOURNAL OF IMMUNOLOGY
- The transcription repressors Bach2 and Bach1 promote B cell development by repressing the myeloid program
- (2014) Ari Itoh-Nakadai et al. NATURE IMMUNOLOGY
- Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids
- (2013) Marie B Condon et al. ANNALS OF THE RHEUMATIC DISEASES
- Cooperative transcriptional repression by BCL6 and BACH2 in germinal center B-cell differentiation
- (2013) C. Huang et al. BLOOD
- Abatacept: A Review of its Use in the Management of Rheumatoid Arthritis
- (2013) Gillian M. Keating DRUGS
- B-cell biology and development
- (2013) Kathrin Pieper et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Distinct Autoantibody Profiles in Systemic Lupus Erythematosus Patients are Selectively Associated with TLR7 and TLR9 Upregulation
- (2013) Sudhir Kumar Chauhan et al. JOURNAL OF CLINICAL IMMUNOLOGY
- IL-21 and CD40L Synergistically Promote Plasma Cell Differentiation through Upregulation of Blimp-1 in Human B Cells
- (2013) B. B. Ding et al. JOURNAL OF IMMUNOLOGY
- Up-regulation of transcription factor Blimp1 in systemic lupus erythematosus
- (2013) Jie Luo et al. MOLECULAR IMMUNOLOGY
- The role of cytokines in the pathogenesis of systemic lupus erythematosus - from bench to bedside
- (2013) Desmond Yat Hin Yap et al. NEPHROLOGY
- Overview of lupus nephritis management guidelines and perspective from Asia
- (2013) Chi Chiu Mok et al. NEPHROLOGY
- Efficacy and safety of epratuzumab in patients with moderate/severe flaring systemic lupus erythematosus: results from two randomized, double-blind, placebo-controlled, multicentre studies (ALLEVIATE) and follow-up
- (2013) Daniel J. Wallace et al. RHEUMATOLOGY
- Efficacy and Safety of Abatacept in Lupus Nephritis: A Twelve-Month, Randomized, Double-Blind Study
- (2013) Richard Furie et al. Arthritis & Rheumatology
- The establishment of early B cell tolerance in humans: lessons from primary immunodeficiency diseases
- (2012) Eric Meffre Annals of the New York Academy of Sciences
- Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
- (2012) George K Bertsias et al. ANNALS OF THE RHEUMATIC DISEASES
- Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus
- (2012) William Stohl et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
- (2012) Brad H. Rovin et al. ARTHRITIS AND RHEUMATISM
- Abatacept for lupus nephritis: Alternative definitions of complete response support conflicting conclusions
- (2012) David Wofsy et al. ARTHRITIS AND RHEUMATISM
- Changes in immune cell frequencies after cyclophosphamide or mycophenolate mofetil treatments in patients with systemic lupus erythematosus
- (2012) Ling Zhao et al. CLINICAL RHEUMATOLOGY
- Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE
- (2012) MA Dooley et al. LUPUS
- Proliferation signal inhibitors in the treatment of lupus nephritis: Preliminary experience
- (2012) DESMOND YH YAP et al. NEPHROLOGY
- Survival analysis and causes of mortality in patients with lupus nephritis
- (2012) D. Y. H. Yap et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Beyond the LUNAR trial. Efficacy of rituximab in refractory lupus nephritis
- (2012) Marc Weidenbusch et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- B-cell numbers and phenotype at clinical relapse following rituximab therapy differ in SLE patients according to anti-dsDNA antibody levels
- (2012) Mark N. Lazarus et al. RHEUMATOLOGY
- Long-term data on corticosteroids and mycophenolate mofetil treatment in lupus nephritis
- (2012) D. Y. H. Yap et al. RHEUMATOLOGY
- American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis
- (2012) Bevra H. Hahn et al. ARTHRITIS CARE & RESEARCH
- Mycophenolic acid counteracts B cell proliferation and plasmablast formation in patients with systemic lupus erythematosus
- (2012) Sebastian Eickenberg et al. ARTHRITIS RESEARCH & THERAPY
- Atacicept in combination with MMF and corticosteroids in lupus nephritis: results of a prematurely terminated trial
- (2012) Ellen M Ginzler et al. ARTHRITIS RESEARCH & THERAPY
- B cell biomarkers of rituximab responses in systemic lupus erythematosus
- (2011) Edward M. Vital et al. ARTHRITIS AND RHEUMATISM
- A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
- (2011) Richard Furie et al. ARTHRITIS AND RHEUMATISM
- Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: Pooled data from European cohorts
- (2011) Cándido Díaz-Lagares et al. AUTOIMMUNITY REVIEWS
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
- (2011) Sandra V Navarra et al. LANCET
- Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis
- (2011) Mary Anne Dooley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Short-term Outcomes of Induction Therapy With Tacrolimus Versus Cyclophosphamide for Active Lupus Nephritis: A Multicenter Randomized Clinical Trial
- (2010) Wei Chen et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Prolonged effects of short-term anti-CD20 B cell depletion therapy in murine systemic lupus erythematosus
- (2010) Kai W. Bekar et al. ARTHRITIS AND RHEUMATISM
- Autostimulatory effects of IL-6 on excessive B cell differentiation in patients with systemic lupus erythematosus: analysis of IL-6 production and IL-6R expression
- (2010) A. KITANI et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Bach2 represses plasma cell gene regulatory network in B cells to promote antibody class switch
- (2010) Akihiko Muto et al. EMBO JOURNAL
- Abnormalities of B cell subsets in patients with systemic lupus erythematosus
- (2010) Thomas Dörner et al. JOURNAL OF IMMUNOLOGICAL METHODS
- TLR9 Regulates TLR7- and MyD88-Dependent Autoantibody Production and Disease in a Murine Model of Lupus
- (2010) Kevin M. Nickerson et al. JOURNAL OF IMMUNOLOGY
- Local Renal Autoantibody Production in Lupus Nephritis
- (2010) M. Espeli et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Pharmacological inhibition of TLR9 activation blocks autoantibody production in human B cells from SLE patients
- (2010) Federica Capolunghi et al. RHEUMATOLOGY
- A polymorphism withinIL21Rconfers risk for systemic lupus erythematosus
- (2009) Ryan Webb et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
- (2009) Joan T. Merrill et al. ARTHRITIS AND RHEUMATISM
- Calcineurin inhibitors affect B cell antibody responses indirectly by interfering with T cell help
- (2009) S. Heidt et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Pathogenesis of kidney disease in systemic lupus erythematosus
- (2009) Harini Bagavant et al. CURRENT OPINION IN RHEUMATOLOGY
- The role of B cells in lupus pathogenesis
- (2009) Emil Nashi et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis
- (2009) G. B. Appel et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- B-cell-directed therapies for autoimmune disease
- (2009) Thomas Dörner et al. Nature Reviews Rheumatology
- Rituximab is an effective treatment for lupus nephritis and allows a reduction in maintenance steroids
- (2009) R. Pepper et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice
- (2009) J. A. Bubier et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study
- (2009) David Isenberg et al. RHEUMATOLOGY
- Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus
- (2008) D Albert et al. ANNALS OF THE RHEUMATIC DISEASES
- Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis
- (2008) G Moroni et al. ANNALS OF THE RHEUMATIC DISEASES
- Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus
- (2008) Michelle Petri et al. ARTHRITIS AND RHEUMATISM
- T Cell-Independent and Toll-like Receptor-Dependent Antigen-Driven Activation of Autoreactive B Cells
- (2008) Robin A. Herlands et al. IMMUNITY
- ICOS-dependent extrafollicular helper T cells elicit IgG production via IL-21 in systemic autoimmunity
- (2008) Jared M. Odegard et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Successful Treatment of Class V+IV Lupus Nephritis with Multitarget Therapy
- (2008) H. Bao et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Rapamycin prevents the development of nephritis in lupus-prone NZB/W F1 mice
- (2008) SL Lui et al. LUPUS
- Rapamycin attenuates the severity of established nephritis in lupus-prone NZB/W F1 mice
- (2008) S. L. Lui et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now